| Code | Description | Claims | Bene. Records | Total Paid |
|---|
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
6,711 |
6,701 |
$346K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,523 |
4,263 |
$204K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,658 |
2,655 |
$174K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,756 |
1,595 |
$100K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,925 |
3,835 |
$90K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
858 |
817 |
$34K |
| 99000 |
|
8,520 |
7,879 |
$33K |
| 99201 |
|
142 |
142 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
111 |
100 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
478 |
467 |
$3K |
| 81002 |
|
854 |
845 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
37 |
37 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
114 |
114 |
$889.19 |
| 81025 |
|
159 |
158 |
$740.09 |
| 0002A |
|
12 |
12 |
$221.42 |
| 0001A |
|
12 |
12 |
$177.89 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
14 |
14 |
$148.75 |
| 81003 |
|
32 |
32 |
$44.60 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
51 |
51 |
$22.86 |
| 99072 |
|
1,295 |
1,212 |
$16.50 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
38 |
38 |
$3.27 |
| 99058 |
|
30 |
28 |
$0.00 |
| S9083 |
Global fee urgent care centers |
15 |
15 |
$0.00 |